DNA-cutting enzymes could slice through gene editing patent spat

Bang Wong, from source material provided by Feng Zhang

Who owns the biggest biotech advance of the century? Geneticists in Boston may have found a way around a high-stakes patent dispute over one of the most significant biotechnology breakthroughs in recent years, a gene-editing tool called CRISPR.

Read the full story in New Scientist.